Patent details

Basic Information

Publication number:

EP1461040

PCT Application Number:

PCT/IB/2002/004380

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP027751437

PCT Publication Number:

WO/2003/045394

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUCCINIC ACID SALTS OF 5,8,14-TRIAZATETRACYCLOÖ10.3.1.0 2,11 .0 4,9 Ü-HEXADECA-2(11),3,5,7,9,-PENTAENE AND PHARMACEUTICAL COMPOSITIONS THEREOF

French Title of Invention:

SELS SUCCINIQUES DE 5,8,14-TRIAZATETRACYCLO 10.3.1.02,11.0 4,9 -HEXADECA-2(11),3,5,7,9-PENTAENE ET COMPOSITIONS PHARMACEUTIQUES ASSOCIEES

German Title of Invention:

SUCCINATE DES 5,8,14-TRIAZATETRACYCLOÖ10.3.1.0 2,11 .0 4,9 Ü-HEXADECA-2(11),3,5,7,9,-PENTAENS UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

21/10/2002

Grant date:

15/03/2006

EP Publication Date:

15/03/2006

PCT Publication Date:

05/06/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/09/2004

EP B1 Publication Date:

15/03/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/10/2006

Expiration date:

21/10/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/10/2002

 

 

Name:

Pfizer Products Inc.

Address:

Eastern Point Road, Groton, Connecticut 06340, United States (US)

Inventor

1

Name:

QUALLICH George, J., Pfizer Global Rch. and Dev.

Address:

United States (US)

2

Name:

WINT Lewin, Theophilus

Address:

United States (US)

Priority

Priority Number:

334245 P

Priority Date:

29/11/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/4995;

Filing date	Document type	Number of pages